Screening for lung cancer using low dose computed tomography

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Tammemagi, Martin C ^a   Lam, Stephen ^b  

^a BROCK UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; EXTERNAL VALIDITY; FALSE POSITIVE RESULT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; LUNG BIOPSY; LUNG CANCER; LUNG NODULE; MENTAL STRESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMOKING HABIT; SYSTEMATIC REVIEW; TUMOR VOLUME;

HUMANS; LUNG NEOPLASMS; MASS SCREENING; RADIATION DOSAGE; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84901710470     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g2253     Document Type: Review

References (129)

1. Brambilla E, Travis WD, Brennan P, Harris CC, Padilla JRP. Lung cancer. In: Stewart BW, Wild CP, eds. World cancer report 2014. International Agency for Research on Cancer, 2014:350-61.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
3. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
4. Boiselle PM, White CS, Ravenel JG. Computed tomographic screening for lung cancer: current practice patterns at leading academic medical centers. JAMA Intern Med 2014;174:286-7.
5. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;11:e442.
6. Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol 2008;3:819-31.
7. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995- 2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
8. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706-14. (Pubitemid 47357522)
9. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic reviewbenefits and harms of ct screening for lung cancer. JAMA 2012;307:2418-29.
10. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation. Ann Intern Med 2013;159:411-20.
11. Manser RL, Irving LB, Byrnes G, Abramson MJ, Stone CA, Campbell DA. Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax 2003;58:784-9. (Pubitemid 37094055)
12. Oken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306:1865-73.
13. Henschke CI. Early lung cancer action project: overall design and findings from baseline screening. Cancer 2000;89:2474-82.
14. Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920-31.
15. Infante M, Lutman FR, Cavuto S, Brambilla G, Chiesa G, Passera E, et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer 2008;59:355-63. (Pubitemid 351335108)
16. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009;180:445-53.
17. Pastorino U, Rossi M, Rosato V, Marchian A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-15.
18. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening trial: status after five annual screening rounds with lowdose CT. Thorax 2012;67:296-301.
19. Van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
20. Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34-40.
21. Lopes Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi FM, et al. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol 2013;8:866-75.
22. Blanchon T, Brechot JM, Grenier PA, Ferretti GR, Lemarie E, Milleron B, et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007;58:50-8. (Pubitemid 47385930)
23. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 2012;138:1475-86.
24. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 2011;66:308-13.
25. Field JK, van Klaveren R, Pedersen JH, JH, Pastorino U, Paci E, Becker N, et al. European randomized lung cancer screening trials: post NLST. J Surg Oncol 2013;108:280-6.
26. Tammemagi MC, Katki HA, Hocking WG, Church T, Caporaso N, Kvale P, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-36.
27. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-54.
28. De Koning H, Meza R, Plevritis S, ten Haaf K, Munshi VN, Jeon J, et al. Benefits and harms of computed tomography lung cancer screening programs for highrisk populations. Agency for Healthcare Research and Quality, 2013. www.uspreventiveservicestaskforce.org/uspstf13/lungcan/lungcanmodeling.htm.
29. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The national lung screening trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 2013;119:3976-83.
30. Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, Macmahon H, et al. Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of the American Association for Thoracic Surgery task force for lung cancer screening and surveillance. J Thorac Cardiovasc Surg 2012;144:25-32.
31. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012;144:33-8.
32. Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:106-17.
33. American Lung Association. American Lung Association provides guidance on lung cancer screening. 2012. www.lung.org/lung-disease/lung-cancer/lungcancer- screening-guidelines.
34. Roberts H, Walker Dilks C, Sivjee K, Ung Y, Yasufuku K, Hey A, et al. Screening high-risk populations for lung cancer - guideline recommendations. J Thorac Oncol 2013;8:1232-7.
35. National Comprehensive Cancer Network clinical practice guidelines for detection, prevention and risk reduction. Version 1.2014. Lung cancer screening. 2014. www.nccn.org/professionals/physician-gls/f-guidelines.asp#lung-screening.
36. Couraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, et al. From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF). Ann Oncol 2013;24:586-97.
37. US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force draft. 2013. www.uspreventiveservicestaskforce. org/draftrec.htm.
38. Moyer VA. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2013; published online 31 Dec.
39. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006;25:127-41. (Pubitemid 43136953)
40. Humphrey L, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer: systematic review to update the US Preventive Services Task Force recommendation. Evidence synthesis no 105. Agency for Healthcare Research and Quality. 2013. www.uspreventiveservicestaskforce.org/ uspstf13/lungcan/lungcanes103.pdf.
41. Bach PB. Perilous potential: the chance to save lives, or lose them, through low dose computed tomography screening for lung cancer. J Surg Oncol 2013;108:287-8.
42. Bunge EM, van den Bergh KA, Essink-Bot ML, van Klaveren RJ, de Koning HJ. High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer. Lung Cancer 2008;62:385-90.
43. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making 2008;28:917-25.
44. McGovern PM, Gross CR, Krueger RA, Engelhard DA, Cordes JE, Church TR. False-positive cancer screens and health-related quality of life. Cancer Nurs 2004;27:347-52. (Pubitemid 39359233)
45. Vierikko T, Kivisto S, Jarvenpaa R, Uitti J, Oksa P, Virtema P, et al. Psychological impact of computed tomography screening for lung cancer and occupational pulmonary disease among asbestos-exposed workers. Eur J Cancer Prev 2009;18:203-6.
46. Van den Bergh KA, Essink-Bot ML, Borsboom GJ, Th Scholten E, Prokop M, de Koning HJ, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010;102:27-34.
47. Van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 2011;38:154-61.
48. Kaerlev L, Iachina M, Pedersen JH, Green A, Norgard BM. CT-screening for lung cancer does not increase the use of anxiolytic or antidepressant medication. BMC Cancer 2012;12:188.
49. Detterbeck FC. Cancer, concepts, cohorts and complexity: avoiding oversimplification of overdiagnosis. Thorax 2012;67:842-5.
50. Grannis FW Jr. Minimizing over-diagnosis in lung cancer screening. J Surg Oncol 2013;108:289-93.
51. Ichinose J, Kohno T, Fujimori S, Harano T, Suzuki S, Fujii T. Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities. Ann Thorac Cardiovasc Surg 2013; published online 3 Oct.
52. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD4, Kramer BS2, Tammemi MC, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174:269-74.
53. Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2012;157:776-84.
54. American Association of Physicists in Medicine. AAPM position statement on radiation risks from medical imaging procedures. 2011. www.aapm.org/org/ policies/details.asp?id=318&type=PP¤t=true.
55. Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012;380:499-505.
56. Harris RP, Sheridan SL, Lewis CL, Barclay C, Vu MB, Kistler CE, et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med 2014;174:281-5.
57. Marshall D, Simpson KN, Earle CC, Chu C. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer 2001;32:227-36. (Pubitemid 32487683)
58. Chirikos TN, Hazelton T, Tockman M, Clark R. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 2002;121:1507-14. (Pubitemid 34499663)
59. Mahadevia PJ, Fleisher LA, Frick KD, Eng J, Goodman SN, Powe NR. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA 2003;289:313-22. (Pubitemid 36083984)
60. Wisnivesky JP, Mushlin AI, Sicherman N, Henschke C. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest 2003;124:614-21. (Pubitemid 37000142)
61. Manser R, Dalton A, Carter R, Byrnes G, Elwood M, Campbell DA. Costeffectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 2005;48:171-85.
62. Black C, Bagust A, Boland A, Walker S, McLeod C, De Verteuil R, et al. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technol Assess 2006;10:iii-iv, ix-x, 1-90.
63. Castleberry AW, Smith D, Anderson C, Rotter AJ, Grannis FW Jr. Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening. Br J Cancer 2009;101:882-96.
64. Reich JM. Cost-effectiveness of computed tomography lung cancer screening. Br J Cancer 2009;101:879-80.
65. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-8.
66. Goulart BH, Bensink ME, Mummy DG, Ramsey SD. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw 2012;10:267-75.
67. Pyenson BS, Sander MS, Jiang Y, Kahn H, Mulshine JL. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff (Millwood) 2012;31:770-9.
68. Shmueli A, Fraifeld S, Peretz T, Gutfeld O, Gips M, Sosna J, et al. Costeffectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience. Value Health 2013;16:922-31.
69. Cressman S, Peacock S, Cromwell I. Resource utilization and costs of screening high-risk individuals for lung cancer in Canada. J Thorac Oncol 2013;8 (suppl):S150.
70. Kantarjian HM, Fojo T, Mathisen M, Zwelling LA. Cancer drugs in the United States: Justum Pretium - the just price. J Clin Oncol 2013;31:3600-4.
71. Fiore M, Jaen C, Baker T, Bailey W, Benowitz N, Curry S, et al. Treating tobacco use and dependence. Clinical practice guideline: Update 2008. US Department of Health and Human Services. Public Health Service; 2008. www.ncbi.nlm.nih.gov/books/NBK63952/.
72. Ashraf H, Tonnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Dossing M. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009;64:388-92.
73. Tammemagi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst [forthcoming].
74. Townsend CO, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer 2005;103:2154-62. (Pubitemid 40605124)
75. Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL. Smoking behavior 1 year after computed tomography screening for lung cancer: Effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomarkers Prev 2009;18:3484-9.
76. International Association for the Study of Lung Cancer (IASLC). Lung Cancer Computed Tomography Screening Workshop 2013 Report. Sydney, Australia, 26-27 October, 2013. J Thorac Oncol [forthcoming].
77. Etzel CJ, Kachroo S, Liu M, D'Amelio A, Dong Q, Cote ML, et al. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila) 2008;1:255-65.
78. Li H, Yang L, Zhao X, Wang J, Qian J, Chen H, et al. Prediction of lung cancer risk in a Chinese population using a multifactorial genetic model. BMC Med Genet 2012;13:118.
79. Park S, Nam BH, Yang HR, Lee JA, Lim H, Han JT, et al. Individualized risk prediction model for lung cancer in Korean men. PLoS One 2013;8:e54823.
80. Maisonneuve P, Bagnardi V, Bellomi M, Spaggiari L, Pelosi G, Rampinelli C, et al. Lung cancer risk prediction to select smokers for screening CT - a model based on the Italian COSMOS trial. Cancer Prev Res (Phila) 2011;4:1778-89.
81. Spitz MR, Etzel CJ, Dong Q, Amos CI, Wei Q, Wu X, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) 2008;1:250-4.
82. Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, Black PN, et al. A genebased risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J 2009;85:515-24.
83. Hippisley-Cox J, Coupland C. Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract 2011;61:e715-23.
84. Iyen-Omofoman B, Tata LJ, Baldwin DR, Smith CJ, Hubbard RB. Using sociodemographic and early clinical features in general practice to identify people with lung cancer earlier. Thorax 2013;68:451-9.
85. Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-26. (Pubitemid 47073532)
86. Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6. (Pubitemid 351161249)
87. Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR,et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011;103:1058-68.
88. Hoggart C, Brennan P, Tjonneland A, Vogel U, Overvad K, Ostergaard JN, et al. A risk model for lung cancer incidence. Cancer Prev Res (Phila) 2012;5:834-46.
89. Hensing TA, Salgia R. Molecular biomarkers for future screening of lung cancer. J Surg Oncol 2013;108:327-33.
90. Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013;368:1980-91.
91. Horeweg N, van der Aalst CM, Vliegenthart R, Zhao Y, Xie X, Scholten ET, et al. Volumetric computer tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-67.
92. McWilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910-9.
93. Pedersen JH, Ashraf H, Dirksen A, Bach K, Hansen H, Toennesen P, et al. The Danish randomized lung cancer CT screening trial - overall design and results of the prevalence round. J Thorac Oncol 2009;4:608-14.
94. Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, et al. Lung cancer screening. J Natl Comprehens Cancer Netw 2012;10:240-65.
95. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395-400. (Pubitemid 41507873)
96. Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer. 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e93S-120S.
97. American College of Radiology Imaging Network. Contemporary screening for the detection of lung cancer. 2013. www.acrin.org/6654-protocol.aspx.
98. Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006;54:177-84. (Pubitemid 44802721)
99. Henschke CI, Yip R, Yankelevitz DF, Smith JP; International Early Lung Cancer Action Program Investigators. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013;158:246-52.
100. Henschke CI, Yip R, Yankelevitz DF, Smith JP. Computed tomography screening for lung cancer. Ann Intern Med 2013;159:156-7.
101. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, Goo JM, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266:304-17.
102. International Early Lung Cancer Action Program Investigators; Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71. (Pubitemid 44631359)
103. Lam S, McWilliams A, Mayo J, Tammemagi M. Computed tomography screening for lung cancer: what is a positive screen? Ann Intern Med 2013;158:289-90.
104. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997;157:849-55. (Pubitemid 28337035)
105. Gurney JW, Lyddon DM, McKay JA. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part II. Application. Radiology 1993;186:415-22. (Pubitemid 23033865)
106. Gould MK, Ananth L, Barnett PG. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007;131:383-8. (Pubitemid 46280396)
107. Schultz EM, Sanders GD, Trotter PR, Patz EF, Jr., Silvestri GA, Owens DK, et al. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax 2008;63:335-41. (Pubitemid 351497946)
108. Balekian AA, Silvestri GA, Simkovich SM, Mestaz PJ, Sanders GD, Daniel J, et al. Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant. Ann Am Thorac Soc 2013;10:629-35.
109. Isbell JM, Deppen S, Putnam JB Jr, Nesbitt JC, Lambright ES, Dawes A, et al. Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg 2011;91:227-33; discussion 33.
110. Tammemagi M, Mayo J, Lam S. Cancer in pulmonary nodules detected on first screening CT - reply to correspondence to the editor. N Engl J Med 2013;369:2061-2.
111. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-65. (Pubitemid 40432263)
112. McWilliams AM, Mayo JR, Ahn MI, MacDonald SL, Lam SC. Lung cancer screening using multi-slice thin-section computed tomography and autofluorescence bronchoscopy. J Thorac Oncol 2006;1:61-8. (Pubitemid 47164022)
113. Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet 2013;382:732-41.
114. Heuvelmans MA, Oudkerk M, de Bock GH, de Koning HJ, Xie X, van Ooijen PM, et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 2013;23:1836-45.
115. Mehta HJ, Ravenel JG, Shaftman SR, Tanner NT, Paoletti L, Taylor KK, et al. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest 2014;145:464-72.
116. Xie X, Zhao Y, Snijder RA, van Ooijen PM, de Jong PA, Oudkerk M, et al. Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16- and 64-row multi-detector CT: an anthropomorphic phantom study. Eur Radiol 2013;23:139-47.
117. Lim HJ, Ahn S, Lee KS, et al. Persistent pure ground-glass opacity lung nodules ≥10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 2013;144:1291-9.
118. Lassen B, van Rikxoort EM, Schmidt M, Kerkstra S, van Ginneken B, Kuhnigk JM. Automatic segmentation of the pulmonary lobes from chest CT scans based on fissures, vessels, and bronchi. IEEE Trans Med Imaging 2013;32:210-22.
119. Jacobs C, Sanchez CI, Saur SC, Twellmann T, de Jong PA, van Ginneken B. Computer-aided detection of ground glass nodules in thoracic CT images using shape, intensity and context features. Med Image Comput Comput Assist Interv 2011;14:207-14.
120. Jacobs C, van Rikxoort EM, Twellmann T, Scholtenet ET, et al. Automatic detection of subsolid pulmonary nodules in thoracic computed tomography images. Med Image Anal 2014;18:374-84.
121. Horeweg N, de Koning HJ. Reply: Stage distribution of lung cancers detected by computed tomography screening in the NELSON trial. Am J Respir Crit Care Med 2013;188:1035-6.
122. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Mandrekar JN. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest 2009;136:1586-95.
123. Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, et al. International Association for the Study of Lung Cancer computed tomography screening workshop 2011 report. J Thorac Oncol 2012;7:10-9.
124. Veronesi G, Maisonneuve P, Rampinelli C, Bertolotti R, Petrella F, Spaggiari L, et al. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model. Lung Cancer 2013;82:426-30.
125. Armato SG, 3rd, Roberts RY, Kocherginsky M, Aberle DR, Kazerooni EA, Macmahon H, et al. Assessment of radiologist performance in the detection of lung nodules: dependence on the definition of "truth." Acad Radiol 2009;16:28-38.
126. Pinsky PF, Gierada DS, Nath PH, Kazerooni E, Amorosa J. National lung screening trial: variability in nodule detection rates in chest CT studies. Radiology 2013;268:865-73.
127. Tammemagi MC, Lam SC, McWilliams AM, Sin DD. Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res (Phila) 2011;4:552-61.
128. Sin D, Tammemagi MC, Lam S, Barnett MJ, Duan X, Tam A, et al. Prosurfactant protein B as a biomarker for lung cancer prediction. J Clin Oncol 2013;31:4536-43.
129. Sozzi G, Boeri M, Rossi M, Verri C, Suatoni P, Bravi F, et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol 2014; published online Jan 13.